Advanced search
Publication Cover
OncoTargets and Therapy Volume 14, 2021 - Issue
Submit an article Journal homepage
143
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Carbonic Anhydrase XII is a Clinically Significant, Molecular Tumor-Subtype Specific Therapeutic Target in Glioma with the Potential to Combat Invasion of Brain Tumor Cells

Guanzhang Li1 Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, People’s Republic of China
,
Ting-Wei Chen2 Clinic for Neurosurgery, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany
,
Ann-Christin Nickel2 Clinic for Neurosurgery, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany
,
Sajjad Muhammad2 Clinic for Neurosurgery, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany
,
Hans-Jakob Steiger2 Clinic for Neurosurgery, Medical Faculty, Heinrich-Heine University, Düsseldorf, GermanyORCID Iconhttps://orcid.org/0000-0002-8249-2998
ORCID Icon,
Theophilos Tzaridis3 Division of Clinical Neurooncology, Department of Neurology and Institute of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, 53127, Germany;4 Tumor Initiation & Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA
,
Daniel Hänggi2 Clinic for Neurosurgery, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany
,
Reinhard Zeidler5 Department for Otorhinolaryngology, Klinikum der Universität München (LMU), Munich, GermanyORCID Iconhttps://orcid.org/0000-0002-3357-4954
ORCID Icon,
Wei Zhang6 Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, People’s Republic of China;7 China National Clinical Research Center for Neurological Diseases, Beijing, People’s Republic of China;8 Chinese Glioma Genome Atlas Network (CGGA) and Asian Glioma Genome Atlas Network (AGGA), Beijing, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-7800-3189
ORCID Icon &
Ulf Dietrich Kahlert1 Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, People’s Republic of China;2 Clinic for Neurosurgery, Medical Faculty, Heinrich-Heine University, Düsseldorf, GermanyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6021-1841
ORCID Icon show all
Pages 1707-1718 | Published online: 04 Mar 2021

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Claudiu T Supuran. (2023) Targeting carbonic anhydrases for the management of hypoxic metastatic tumors. Expert Opinion on Therapeutic Patents 0:0, pages 1-20.
Read now
Claudiu T. Supuran. (2021) Carbonic anhydrase inhibitors: an update on experimental agents for the treatment and imaging of hypoxic tumors. Expert Opinion on Investigational Drugs 30:12, pages 1197-1208.
Read now

Articles from other publishers (7)

Catarina I.G. Pinto, Joana F. Guerreiro, Francisco Silva, Filipa Mendes & António Paulo. 2023. New Insights Into Glioblastoma. New Insights Into Glioblastoma 667 705 .
Yan Yin, Wei Du & Fei Li. (2022) The construction of a hypoxia-based signature identified CA12 as a risk gene affecting uveal melanoma cell malignant phenotypes and immune checkpoint expression. Frontiers in Oncology 12.
Crossref
Taisuke Matsue, Min Gi, Masayuki Shiota, Hirokazu Tachibana, Shugo Suzuki, Masaki Fujioka, Anna Kakehashi, Tomoki Yamamoto, Minoru Kato, Junji Uchida & Hideki Wanibuchi. (2022) The carbonic anhydrase inhibitor acetazolamide inhibits urinary bladder cancers via suppression of β‐catenin signaling. Cancer Science 113:8, pages 2642-2653.
Crossref
Qian Gao, Lirong Chen, Chenshuang Jia, Yue Yuan, Xinyao Li, Zheng Lu, Yang Feng, Ruixia Zhao, Xuewei Zhao, Yiwen Wang, Sinan Cheng, Caixia Zhang, Jie Xu, Zhan Shu, Wei Duan, Guochao Nie, Li Xiao & Yingchun Hou. (2022) Selection and identification of a specific peptide binding to ovarian cancer cells from a phage-displayed peptide library. Biotechnology Letters 44:8, pages 951-960.
Crossref
FeiYan Ai, Wenhao Wang, Shaojun Liu, Decai Zhang, Zhenyu Yang & Fen Liu. (2022) Integrative Proteo-Genomic Analysis for Recurrent Survival Prognosis in Colon Adenocarcinoma. Frontiers in Oncology 12.
Crossref
Ke Shi, Xinxin Li, Jingfa Zhang & Xiaodong Sun. (2022) Development and Validation of a Novel Metabolic Signature-Based Prognostic Model for Uveal Melanoma. Translational Vision Science & Technology 11:5, pages 9.
Crossref
Fangli Chen, Emilia Licarete, Xue Wu, Daniela Petrusca, Callista Maguire, Max Jacobsen, Austyn Colter, George E. Sandusky, Magdalena Czader, Maegan L. Capitano, James P. Ropa, H. Scott Boswell, Fabrizio Carta, Claudiu T. Supuran, Brian Parkin, Melissa L. Fishel & Heiko Konig. (2021) Pharmacological inhibition of Carbonic Anhydrase IX and XII to enhance targeting of acute myeloid leukaemia cells under hypoxic conditions. Journal of Cellular and Molecular Medicine 25:24, pages 11039-11052.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.